Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pha...
Zacks Investment Research downgraded shares of Athersys (NASDAQ:ATHX – Get Rating) from a buy rating to a hold rating in a report published on Tuesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are […]
Press release content from Business Wire. The AP news staff was not involved in its creation.
Company presentations scheduled at the Locust Walk Stem Cell Conference, April 11, and at the Needham Healthcare Conference, April 13CLEVELAND--(BUSINESS WIRE)--$ATHX #Athersys--Athersys, Inc. (Nasdaq: ATHX) announced today that William (B.J.) Lehmann, President and Chief Operating Officer, will present a corporate...
Athersys, Inc. (NASDAQ:ATHX – Get Rating) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 18,980,000 shares, an increase of 24.1% from the February 28th total of 15,300,000 shares. Based on an average trading volume of 1,460,000 shares, the short-interest ratio is presently 13.0 days. In […]